Cargando…

Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer

Klotho, a cellular anti-senescence protein, is related to antitumor actions, growth regulation, proliferation and invasiveness in several types of tumor, including breast cancer. The present study aimed to analyze the serum levels of αKlotho in patients with breast cancer according to histopathologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Borges, Bruna Cristina, Do Amaral, Pedro Augusto, Soldi, Luiz Ricardo, Costa Silva, Victor Luigi, Carvalho De Souza, Fernanda, Cordeiro Da Luz, Felipe Andrés, Agenor De Araújo, Rogério, Barbosa Silva, Marcelo José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943645/
https://www.ncbi.nlm.nih.gov/pubmed/35350405
http://dx.doi.org/10.3892/mco.2022.2526
_version_ 1784673564675276800
author Borges, Bruna Cristina
Do Amaral, Pedro Augusto
Soldi, Luiz Ricardo
Costa Silva, Victor Luigi
Carvalho De Souza, Fernanda
Cordeiro Da Luz, Felipe Andrés
Agenor De Araújo, Rogério
Barbosa Silva, Marcelo José
author_facet Borges, Bruna Cristina
Do Amaral, Pedro Augusto
Soldi, Luiz Ricardo
Costa Silva, Victor Luigi
Carvalho De Souza, Fernanda
Cordeiro Da Luz, Felipe Andrés
Agenor De Araújo, Rogério
Barbosa Silva, Marcelo José
author_sort Borges, Bruna Cristina
collection PubMed
description Klotho, a cellular anti-senescence protein, is related to antitumor actions, growth regulation, proliferation and invasiveness in several types of tumor, including breast cancer. The present study aimed to analyze the serum levels of αKlotho in patients with breast cancer according to histopathological and immunohistochemical variables. A total of 74 patients and 60 healthy controls were recruited. Peripheral blood samples were collected and serum levels were assessed by sandwich ELISA. Clinical and diagnostic data were obtained from medical records and databases of the Clinical Hospital of the Federal University of Uberlândia (Uberlândia, Brazil). The results indicated no difference in the levels of αKlotho between patients and controls (P=0.068); however, the number of patients with breast cancer with undetectable αKlotho was high (n=52). Thus, the variables that were associated with the lowest survival rates were analyzed, relating them to undetectable αKlotho. Among cases of metastatic tumors or tumors with poor differentiation, positive lymph node status and triple-negative status, patients with undetectable αKlotho predominated and had unfavorable overall survival. Due to the significant results obtained in triple-negative patients, an in vitro analysis was performed to determine whether estrogen receptors (ERs) have a role in αKlotho production. Treatment of MCF-7 cells with ER agonists, estradiol (E2) and diarylpropionitrile (DPN), resulted in increases in αKlotho expression and supernatant levels of both agonists, demonstrating a direct association between the ER and Klotho production; of note, the ERβ-specific agonist DPN tripled αKlotho expression when compared to E2 (P=0.078). These data suggested that undetectable αKlotho in the serum of patients with breast cancer is related to unfavorable histopathological variables and poor prognosis and ERs possibly have an important role in maintaining adequate quantities of αKlotho.
format Online
Article
Text
id pubmed-8943645
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-89436452022-03-28 Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer Borges, Bruna Cristina Do Amaral, Pedro Augusto Soldi, Luiz Ricardo Costa Silva, Victor Luigi Carvalho De Souza, Fernanda Cordeiro Da Luz, Felipe Andrés Agenor De Araújo, Rogério Barbosa Silva, Marcelo José Mol Clin Oncol Articles Klotho, a cellular anti-senescence protein, is related to antitumor actions, growth regulation, proliferation and invasiveness in several types of tumor, including breast cancer. The present study aimed to analyze the serum levels of αKlotho in patients with breast cancer according to histopathological and immunohistochemical variables. A total of 74 patients and 60 healthy controls were recruited. Peripheral blood samples were collected and serum levels were assessed by sandwich ELISA. Clinical and diagnostic data were obtained from medical records and databases of the Clinical Hospital of the Federal University of Uberlândia (Uberlândia, Brazil). The results indicated no difference in the levels of αKlotho between patients and controls (P=0.068); however, the number of patients with breast cancer with undetectable αKlotho was high (n=52). Thus, the variables that were associated with the lowest survival rates were analyzed, relating them to undetectable αKlotho. Among cases of metastatic tumors or tumors with poor differentiation, positive lymph node status and triple-negative status, patients with undetectable αKlotho predominated and had unfavorable overall survival. Due to the significant results obtained in triple-negative patients, an in vitro analysis was performed to determine whether estrogen receptors (ERs) have a role in αKlotho production. Treatment of MCF-7 cells with ER agonists, estradiol (E2) and diarylpropionitrile (DPN), resulted in increases in αKlotho expression and supernatant levels of both agonists, demonstrating a direct association between the ER and Klotho production; of note, the ERβ-specific agonist DPN tripled αKlotho expression when compared to E2 (P=0.078). These data suggested that undetectable αKlotho in the serum of patients with breast cancer is related to unfavorable histopathological variables and poor prognosis and ERs possibly have an important role in maintaining adequate quantities of αKlotho. D.A. Spandidos 2022-04 2022-02-25 /pmc/articles/PMC8943645/ /pubmed/35350405 http://dx.doi.org/10.3892/mco.2022.2526 Text en Copyright: © Borges et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Borges, Bruna Cristina
Do Amaral, Pedro Augusto
Soldi, Luiz Ricardo
Costa Silva, Victor Luigi
Carvalho De Souza, Fernanda
Cordeiro Da Luz, Felipe Andrés
Agenor De Araújo, Rogério
Barbosa Silva, Marcelo José
Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer
title Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer
title_full Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer
title_fullStr Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer
title_full_unstemmed Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer
title_short Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer
title_sort undetected αklotho in serum is associated with the most aggressive phenotype of breast cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943645/
https://www.ncbi.nlm.nih.gov/pubmed/35350405
http://dx.doi.org/10.3892/mco.2022.2526
work_keys_str_mv AT borgesbrunacristina undetectedaklothoinserumisassociatedwiththemostaggressivephenotypeofbreastcancer
AT doamaralpedroaugusto undetectedaklothoinserumisassociatedwiththemostaggressivephenotypeofbreastcancer
AT soldiluizricardo undetectedaklothoinserumisassociatedwiththemostaggressivephenotypeofbreastcancer
AT costasilvavictorluigi undetectedaklothoinserumisassociatedwiththemostaggressivephenotypeofbreastcancer
AT carvalhodesouzafernanda undetectedaklothoinserumisassociatedwiththemostaggressivephenotypeofbreastcancer
AT cordeirodaluzfelipeandres undetectedaklothoinserumisassociatedwiththemostaggressivephenotypeofbreastcancer
AT agenordearaujorogerio undetectedaklothoinserumisassociatedwiththemostaggressivephenotypeofbreastcancer
AT barbosasilvamarcelojose undetectedaklothoinserumisassociatedwiththemostaggressivephenotypeofbreastcancer